EN 中文
Home Strategic Partnerships News Contact us
TOTAL:41 NEWS
Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2021 China Top 100 Innovative Biotech Companies List”
read
2022-09-21
87
Zhaoke Ophthalmology Announces 2022 Interim Results
read
2022-08-25
283
First Patient Enrolled in Phase II Clinical Trial of Zhaoke Ophthalmology’s ZKY001 For Transepithelial Photorefractive Keratectomy (TPRK)
read
2022-08-11
183
Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002
read
2022-08-03
206
First Patient Enrolled for Phase III Clinical Trial of Zhaoke Ophthalmology’s wet Age-related Macular Degeneration (wAMD) Drug, TAB014
read
2022-07-07
258
>
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat